Part A~To assess the safety and tolerability of single ascending oral doses of FB-101 in healthy subjects.~To assess the pharmacokinetics (PK) of single ascending oral doses of FB-101 in healthy subjects.~To assess the effect of a high-fat meal on the PK of a single oral dose of FB-101 when administered to healthy subjects.~Part B~To assess the safety and tolerability of multiple ascending oral doses FB-101 in healthy subjects.~To assess the PK of multiple ascending oral doses of FB-101 in healthy subjects.
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of oral doses of FB-101 in healthy subjects.